- Home
- SEED vs CELZ Comparison
SEED vs CELZ Comparison
Compare SEED & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEED | CELZ |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 10.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SEED | CELZ |
|---|---|---|
| Price | $1.56 | $2.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.1K | ★ 124.3K |
| Earning Date | 06-26-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,910,081.00 | $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.74 | $1.69 |
| 52 Week High | $2.70 | $6.90 |
Technical Indicators
Market Signals| Indicator | SEED | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 34.01 |
| Support Level | $1.25 | $2.08 |
| Resistance Level | $1.46 | $2.41 |
| Average True Range (ATR) | 0.11 | 0.22 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 97.48 | 14.02 |
Price Performance
Historical ComparisonAbout SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.